seed
Stage
2
Investors
About
Solvemed Group develops a smartphone-based FDA Class I medical device called PuRe™ Pupillometer that enables accurate, lighting-invariant pupillary size and reactivity testing integrated with hospital EMR systems without requiring additional hardware.
Explore Solvemed Group's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.